GAMBARI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 60.011
AS - Asia 33.390
EU - Europa 27.533
SA - Sud America 5.317
AF - Africa 728
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 27
AN - Antartide 1
Totale 127.090
Nazione #
US - Stati Uniti d'America 58.906
SG - Singapore 12.499
FI - Finlandia 10.475
CN - Cina 8.820
BR - Brasile 4.216
VN - Vietnam 3.385
IT - Italia 3.244
DE - Germania 3.061
UA - Ucraina 3.001
HK - Hong Kong 2.689
TR - Turchia 2.099
GB - Regno Unito 1.737
PL - Polonia 1.729
SE - Svezia 1.148
FR - Francia 1.106
RU - Federazione Russa 855
JP - Giappone 815
IN - India 704
CA - Canada 495
ID - Indonesia 464
MX - Messico 453
AR - Argentina 398
BD - Bangladesh 381
NL - Olanda 291
ZA - Sudafrica 263
IQ - Iraq 255
PK - Pakistan 195
EC - Ecuador 183
ES - Italia 173
CO - Colombia 142
BE - Belgio 140
PH - Filippine 121
UZ - Uzbekistan 119
VE - Venezuela 113
MA - Marocco 112
CL - Cile 107
IR - Iran 107
SA - Arabia Saudita 99
MY - Malesia 95
AT - Austria 91
LT - Lituania 85
AE - Emirati Arabi Uniti 70
AU - Australia 66
TN - Tunisia 66
EG - Egitto 63
PY - Paraguay 60
CZ - Repubblica Ceca 57
KE - Kenya 53
KR - Corea 52
NP - Nepal 43
DZ - Algeria 42
RO - Romania 41
GR - Grecia 39
JO - Giordania 39
IL - Israele 37
PE - Perù 37
TH - Thailandia 34
AZ - Azerbaigian 33
CH - Svizzera 33
ET - Etiopia 32
IE - Irlanda 32
JM - Giamaica 32
UY - Uruguay 31
BO - Bolivia 25
PT - Portogallo 25
AL - Albania 24
KZ - Kazakistan 24
LB - Libano 24
TW - Taiwan 23
OM - Oman 22
PA - Panama 21
CR - Costa Rica 20
EU - Europa 18
BG - Bulgaria 17
NG - Nigeria 17
PS - Palestinian Territory 17
RS - Serbia 16
SY - Repubblica araba siriana 16
DK - Danimarca 15
DO - Repubblica Dominicana 15
KG - Kirghizistan 14
KW - Kuwait 14
LV - Lettonia 14
NZ - Nuova Zelanda 14
BH - Bahrain 13
TT - Trinidad e Tobago 12
LY - Libia 11
MD - Moldavia 11
AO - Angola 10
GE - Georgia 10
HU - Ungheria 10
NI - Nicaragua 10
SN - Senegal 10
SV - El Salvador 10
EE - Estonia 9
KH - Cambogia 9
SI - Slovenia 9
BB - Barbados 8
GT - Guatemala 8
LK - Sri Lanka 8
Totale 126.916
Città #
Helsinki 9.636
Singapore 7.779
Ashburn 6.720
Woodbridge 5.602
Fairfield 5.235
San Jose 3.661
Houston 3.430
Jacksonville 3.345
Chandler 3.065
Ann Arbor 2.971
Beijing 2.888
Hong Kong 2.638
Santa Clara 2.399
Seattle 2.081
Wilmington 1.985
Warsaw 1.689
Cambridge 1.641
Izmir 1.132
Ho Chi Minh City 1.127
Nanjing 1.003
Ferrara 913
New York 809
Hanoi 805
Los Angeles 797
Princeton 778
Tokyo 774
Dallas 764
Lauterbourg 678
Munich 597
Boardman 559
San Diego 456
Council Bluffs 446
Shanghai 359
São Paulo 353
Milan 345
Shenyang 308
Addison 305
Jakarta 305
Nanchang 295
Bremen 285
Mexico City 279
Tianjin 239
London 230
Orem 215
Hebei 203
Changsha 198
Hefei 196
Bologna 186
Turku 182
Chicago 177
Redwood City 166
Rio de Janeiro 160
Falls Church 159
Da Nang 155
Brooklyn 151
Buffalo 151
Jiaxing 151
Moscow 151
The Dalles 149
Montreal 145
Chennai 140
Haiphong 139
Mountain View 134
Jinan 133
Frankfurt am Main 131
Johannesburg 130
Brussels 129
Denver 126
San Francisco 126
Atlanta 120
Toronto 119
Falkenstein 117
Stockholm 117
Dearborn 113
Verona 110
Porto Alegre 108
Zhengzhou 108
San Mateo 106
Guangzhou 104
Baghdad 103
Rome 103
Phoenix 100
Tashkent 99
Norwalk 98
Amsterdam 97
Boston 92
Belo Horizonte 91
Ningbo 88
Manchester 84
Auburn Hills 81
Hangzhou 81
Des Moines 79
Poplar 78
Dong Ket 77
Nuremberg 71
Curitiba 70
Kunming 69
Columbus 68
Philadelphia 67
Ankara 66
Totale 88.673
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.014
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.974
SYNTHETIC OLIGONUCLEOTIDES AS INDUCERS OF ERYTHROID DIFFERENTIATION 1.967
Derivati 3-deossi-3-ammidici e 3-deossi-3-chetonici di carboidrati come induttori del differenziamento 1.963
Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale Distamicina A 1.962
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 523
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 413
A validated cellular biobank for β-thalassemia 412
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis 399
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 375
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 372
Pyrazolo-triazoles as light activable dna cleaving agents 370
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 363
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 345
A validated THALAMOSS cellular biobank for β-thalassemia 331
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Ew trends in the development of miRNA therapeutic strategies in oncology 330
Bis(dimethylsulfoxide)carbonateplatinum(II), a new synthon for a low-impact, versatile synthetic route to anticancer Pt carboxylates 305
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 301
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 300
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 296
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 295
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 292
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 271
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties 271
Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery 271
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 270
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 270
"In vivo" local transfection of a cis element decoy mimicking an estrogen receptor alpha gene promoter region induces apoptosis of osteoclasts following application of orthodontic forces to rat teeth 270
Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients 267
Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells 258
SPR-based non-invasive prenatal testing for fetal sex determination 253
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 252
Alteration of the expression of human estrogen receptor gene by distamycin 250
Moringa oleifera leaf extracts as multifunctional ingredients for “natural and organic” sunscreens and photoprotective preparations 250
Transcription factor decoy against NFATc1 in human primary osteoblasts 250
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 249
Phloridzin derivatives inhibiting proinflammatory cytokine expression in human cystic fibrosis IB3-1 cells 244
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 243
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 242
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 242
5-(Dimethylamino)-N-(4-ethynylphenyl)-1-naphthalenesulfonamide as a novel bifunctional antitumor agent and two-photon induced bio-imaging probe 240
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 240
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells 236
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 236
A chromatographic procedure for fully automated isolation of DNA from human whole blood 235
Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells 235
A non-radioactive automated protocol to study protein-DNA interactions by DNase I footprinting 235
Analytic and dynamic secretory profile of patient-derived cytokine-Induced killer cells 235
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 235
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 234
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 234
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 234
Ethanolic extract from Hemidesmus indicus (Linn) displays otoprotectant activities on organotypic cultures without interfering on gentamicin uptake 233
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 232
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 232
Synthesis and characterization of Pt complexes containing dichloroacetate (DCA), designed for dual anticancer action 232
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 232
Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors 231
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 231
Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices 230
Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology. 229
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 229
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 227
Comparative antiproliferative activities of wood and seeds essential oils of Juniperus oxycedrus L. against K562 human chronic myelogenus leukemia cells. 227
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 226
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 226
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 226
Analysis of upstream sequences of the humasn estrogen receptor gene 225
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 224
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 223
Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues 221
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 221
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 220
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 220
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 220
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 219
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 219
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 219
c-myc oncogene alterations in human thyroid carcinomas. 218
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 217
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 217
Modulation of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) gene expression in isolated porcine hepatocytes perfused within a radial-flow bioreactor after low-temperature storing 216
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 216
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 215
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 214
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 214
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 214
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 212
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 212
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 212
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 212
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 212
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 211
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies 211
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 211
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 211
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 210
In vitro evaluation of anti-proliferative and geno-protective activity of Hemidesmus indicus crude drug extracts 209
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 209
Totale 33.921
Categoria #
all - tutte 523.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 19.564
Totale 543.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.344 0 0 0 0 0 0 0 0 0 0 1.504 840
2021/20227.613 472 714 461 307 503 381 387 394 289 655 830 2.220
2022/20237.303 841 513 190 946 1.270 1.046 308 643 811 56 408 271
2023/20244.258 354 561 194 111 433 771 198 458 59 62 136 921
2024/202515.531 439 371 1.345 645 1.816 1.182 524 905 2.624 1.916 2.130 1.634
2025/202650.447 4.054 1.869 3.735 5.523 5.943 2.751 5.242 2.547 13.572 5.108 103 0
Totale 128.532